A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

To build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS ...

Study uncovers how the protein hnRNP A1 may impact myelin stability, offering new clues in schizophrenia development.

"Without that [Agency for Healthcare Research and Quality] support, we will become ineffective." -- former U.S. Preventive ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

slowed disability progression by 31% in patients with nonrelapsing secondary progressive multiple sclerosis (nrSPMS), results of a multi-center phase 3 study showed. “Although tolebrutinib was ...

Selma Blair discusses her health journey, updating fans on her Multiple Sclerosis, sharing her diagnosis story, and revealing ...

Dr Pavan Bhargava recently returned from the 2025 AAN Annual Meeting, where key updates in relapsing-remitting multiple sclerosis (RRMS) were highlighted. He noted the introduction of the 2024 ...